Prognostic implications of left ventricular hypertrophy defined by the thresholds from the international and Chinese

Dan Zhou1, Mengqi Yan1, Anping Cai1,2

  • 1Department of Cardiology, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, People's Republic of China.

Insights

Chinese thresholds for left ventricular hypertrophy (LVH) better predict mortality in hypertensive patients than international guidelines. Using race-specific thresholds and indexing left ventricular mass (LVM) to BSA or height^1.7 improves risk stratification.

Area of Science:

  • Cardiology
  • Hypertension Research
  • Medical Statistics

Background:

  • Left ventricular hypertrophy (LVH) is a significant predictor of mortality in hypertensive individuals.
  • Current international guidelines for defining LVH may not be optimal for all populations.
  • Accurate LVH assessment is crucial for cardiovascular risk stratification.

Purpose of the Study:

  • To compare the predictive value of mortality between LVH defined by Chinese thresholds and international guidelines in Chinese hypertensive patients.
  • To identify optimal methods for indexing left ventricular mass (LVM) in the Chinese population for LVH assessment.
  • To investigate the association between different LVH definitions and all-cause and cardiovascular mortality.

Main Methods:

  • A cohort of 2454 community hypertensive patients with measured LVM and relative wall thickness was analyzed.
  • LVM was indexed to body surface area (BSA), height^2.7, and height^1.7.
  • Cox proportional hazards models, C-statistics, and time-dependent ROC curves were used to evaluate LVH prediction of mortality.

Main Results:

  • LVH defined by Chinese thresholds (LVM/BSA) was significantly associated with cardiovascular mortality.
  • Both LVM/BSA and LVM/Height^1.7, using Chinese thresholds, showed significant associations with all-cause mortality.
  • Chinese thresholds for LVM/BSA and LVM/Height^1.7 demonstrated superior predictive ability for mortality compared to international guidelines.

Conclusions:

  • Race-specific thresholds are recommended for classifying LVH and improving mortality risk stratification in Chinese hypertensive populations.
  • LVM indexed to BSA and height^1.7 are acceptable normalization methods for LVH assessment in Chinese hypertensive patients.
  • Utilizing appropriate LVH definitions and indexing methods enhances the prediction of adverse outcomes in hypertension.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
17
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
16
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
21
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
19
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
18
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.7K